COVID-19 Testing and Vaccination Among Spanish Speakers
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT05302908
- Status
- Completed
Conditions
- COVID-19
- Vaccinations
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- NuestraSaludSegura — BEHAVIORALIt blends peer navigation and mHealth
Study Details
Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist, and a profound need remains to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination within Latinx communities. Our community-academic partnership proposes a rigorous mixed-methods, community-based participatory research study to better understand the SEBI of COVID-19 testing and vaccination and to refine and test a novel and culturally congruent intervention that integrates two evidenced-based strategies - peer navigation and mHealth - to increase COVID-19 testing and vaccination within Spanish-speaking Latinx communities.
Key Dates
- Start date
- Feb 9, 2023
- Status verified
- Dec 2025
- Primary completion
- Nov 30, 2024
- Completion
- Nov 30, 2024
Study Design
- Enrollment
- 274 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: NuestraSaludSegura interventionIntervention-group Navegantes will be trained and supported for 6 months of implementation in Years 1-2
- Experimental: delayed NuestraSaludSegura interventiondelayed-intervention group Navegantes will be trained in Year 2
Primary Outcome Measure
Number of Subjects Ever Tested [ Time Frame: Baseline ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | - |
Find similar trials in Winston-Salem, NC
Related Studies
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyPHASE3 · Recruiting · Ansun Biopharma, Inc. · Duarte, California
- Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19Enrolling By Invitation · Duke University · Durham, North Carolina
- REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19Recruiting · Duke University · Birmingham, Alabama
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseasePHASE3 · Recruiting · Pfizer · Phoenix, Arizona